Search

Displaying results 9931 - 9940 of 10000 in total
  1. Drug

    Semotiadil

    go.drugbank.com/drugs/DB20587
    Experimental

    The usage of the INN stem '-dil' in the name indicates that Semotiadil is a vasodilator. Semotiadil has a monoisotopic molecular weight of 536.2 Da.

  2. Drug

    Floredil

    go.drugbank.com/drugs/DB20906
    Experimental

    The usage of the INN stem '-dil' in the name indicates that Floredil is a vasodilator. Floredil has a monoisotopic molecular weight of 295.18 Da.

  3. Drug

    Carprazidil

    go.drugbank.com/drugs/DB21012
    Experimental

    The usage of the INN stem '-dil' in the name indicates that Carprazidil is a vasodilator. Carprazidil has a monoisotopic molecular weight of 291.1 Da.

  4. Drug

    Tinofedrine

    go.drugbank.com/drugs/DB21039
    Experimental

    The usage of the INN stem '-drine' in the name indicates that Tinofedrine is a sympathomimetic. Tinofedrine has a monoisotopic molecular weight of 355.11 Da.

  5. Drug

    Rociletinib

    go.drugbank.com/drugs/DB11907
    Investigational

    Rociletinib has been used in trials studying the treatment and prevention of Nonsmall Cell Lung Cancer, Non-small Cell Lung Cancer, and Locally Advanced or Metastatic Non-small Cell Lung Cancer.

  6. Drug

    6-O-benzylguanine

    go.drugbank.com/drugs/DB11919
    Investigational

    6-O-benzylguanine has been used in trials studying the treatment of HIV Infection, Adult Gliosarcoma, Adult Glioblastoma, Stage I Adult Hodgkin Lymphoma, and Stage II Adult Hodgkin Lymphoma, among others

  7. Drug

    ASP-3026

    go.drugbank.com/drugs/DB12729
    Investigational

    ASP3026 has been used in trials studying the treatment of Solid Tumor, B-Cell Lymphoma, Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, and Positive for Proto-Oncogene Tyrosine-Protein

  8. Drug

    MKC-1

    go.drugbank.com/drugs/DB05608
    Investigational

  9. Drug

    IPH 1101

    go.drugbank.com/drugs/DB05754
    Experimental

    IPH 1101 is a chemically-synthesized structural analog of non-conventional bacterial phosphoantigens which specifically activate the Vγ9Vδ2 T cell subset. IPH 1101 is the most advanced drug candidate of the γδ T cell platform

  10. Drug

    Vadimezan

    go.drugbank.com/drugs/DB06235
    Investigational